» Articles » PMID: 12063293

Role of USF1 Phosphorylation on Cardiac Alpha-myosin Heavy Chain Promoter Activity

Overview
Date 2002 Jun 14
PMID 12063293
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Contractile activity of the cardiac myocyte is required for maintaining cell mass and phenotype, including expression of the cardiac-specific alpha-myosin heavy chain (alpha-MHC) gene. An E-box hemodynamic response element (HME) located at position -47 within the alpha-MHC promoter is both necessary and sufficient to confer contractile responsiveness to the gene and has been shown to bind upstream stimulatory factor-1 (USF1). When studied in spontaneously contracting cardiac myocytes, there is enhanced binding of USF1 to the HME compared with quiescent cells, which correlates with a threefold increase in alpha-MHC promoter activity. A molecular mechanism by which contractile function modulates alpha-MHC transcriptional activity may involve signaling via phosphorylation of USF1. The present studies showed that purified rat USF1 was phosphorylated in vitro by protein kinase C (PKC) and cAMP-dependent protein kinase (PKA) but not casein kinase II. Phosphorylated USF1 by either PKC or PKA had increased DNA binding activity to the HME. PKC-mediated phosphorylation also leads to the formation of USF1 multimers as assessed by gel shift assay. Analysis of in vivo phosphorylated nuclear proteins from cultured ventricular myocytes showed that USF1 was phosphorylated, and resolution by two-dimensional gel electrophoresis identified at least two distinct phosphorylated USF1 molecules. These results suggest that endogenous kinases can covalently modify USF1 and provide a potential molecular mechanism by which the contractile stimulus mediates changes in myocyte gene transcription.

Citing Articles

Upstream Stimulatory Factors Regulate HIV-1 Latency and Are Required for Robust T Cell Activation.

Horvath R, Sadowski I Viruses. 2023; 15(7).

PMID: 37515158 PMC: 10384547. DOI: 10.3390/v15071470.


CMV enhancer may not be suitable for tissue-specific enhancement of promoters in cancer gene therapy.

Jia Z, Jia J, Zhang S, Cao J Cancer Gene Ther. 2019; 27(5):389-392.

PMID: 31130730 DOI: 10.1038/s41417-019-0106-x.


Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer.

Horbach T, Gotz C, Kietzmann T, Dimova E Front Pharmacol. 2015; 6:3.

PMID: 25741280 PMC: 4332324. DOI: 10.3389/fphar.2015.00003.


GSK3β-dependent phosphorylation alters DNA binding, transactivity and half-life of the transcription factor USF2.

Horbach T, Chi T, Gotz C, Sharma S, Juffer A, Dimova E PLoS One. 2014; 9(9):e107914.

PMID: 25238393 PMC: 4169611. DOI: 10.1371/journal.pone.0107914.


Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia.

Pawlus M, Wang L, Ware K, Hu C Mol Cell Biol. 2012; 32(22):4595-610.

PMID: 22966206 PMC: 3486188. DOI: 10.1128/MCB.00724-12.